Purdue takes over production of TB drug

Eli Lilly and Co. has completed shifting exclusive production of a tuberculosis antibiotic to Purdue Research Foundation.

The foundation’s Chao Center for Industrial Pharmacy & Contract Manufacturing will manufacture and distribute the drug, called Seromycin. Lilly sold the rights for an undisclosed price and donated the manufacturing equipment.

Approximately 10,000 Americans are thought to have a form of the disease that is resistant to other antibiotics.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}